Serina Therapeutics, Inc. Q4 FY2021 Earnings Call

Serina Therapeutics, Inc. (SER)

Earnings Call FY2021 Q4 Call date: 2022-03-29 Concluded

Quarter scorecard

Revenue (derived Q4)

$27,000

-82.9% YoY

Gross margin (derived Q4)

96.3%

-0.5 pp YoY

Net income (derived Q4)